Life Science Instrumentation Market Growth, Size, Opportunity, Share, Forecast 2019-2025

Recent advancement such as microarray-based expression profiling in genomics, proteomics and drug discovery domains, created new possibilities for the diagnosis and treatment of various fatal diseases such as Cancer and CVD. The life science instrument supported R&D programs and other research studies to discover and develop safe and effective drugs for various chronic diseases including Cancer, Diabetes, and neurological diseases, among others. Research programs related to human genetics have been analyzed in combination with health data and have become increasingly vital for understanding the most complex diseases.

Request a Free Sample of our Report on Life Science Instrumentation Market: https://www.omrglobal.com/request-sample/life-science-instrumentation-market

Government grants and funding are expected to boost the research programs for the prevention, diagnosis, treatment, intervention, and discovery of new drugs. To support these researches, focus on sharing and establishment of resources consisting of data, biological samples and information derived from the analysis are taken into consideration.

R&D budget have been increased around the globe owing to increasing funding, grants and other government support in R&D for drug discovery. The increase in R&D expenditure is also driven by increasing pharmaceutical sales coupled with technological advancement. Significant increase in government funding for R&D programs have boosted drug discovery industry and other associated markets such as life science instrumentation. In 2018, it was stated by the NIH (National Institutes of Health), one of the foremost medical research centers, globally, that it invests around $39 billion for medical research in the US annually. Over 80% of the organization’s funding is granted through around 50,000 competitive grants to over 300,000 researchers at research institutions, medical schools, and universities across the US and other economies.

Advancement in NGS further contribute significantly to the life science Instrumentation market

Next-generation sequencing (NGS), also known as high-throughput sequencing, is the catch-all term that is used to describe a number of different modern sequencing technologies such as Illumina (Solexa) sequencing, Roche 454 sequencing, Ion torrent: Proton / PGM sequencing, SOLiD sequencing and so on. These recent technologies allow us to sequence DNA and RNA much more quickly and cheaply than the previously used Sanger sequencing. Such technologies have therefore revolutionized the study of genomics and molecular biology therefore creating significant market during the forecast period.

The advancements in next generation sequencing is driving the R&D programs across the globe. Companies such as Thermo fisher Scientific, Roche, Illumina Inc., Knome Inc., Life technologies, International Business Machines Corp., Genia, Oxford Nanopore Technologies and so on are contributing significantly toward the advancement of next generation sequencing. Thermo Fisher Scientific is positive on the U.S. FDA approval for the first next-generation sequencing-based companion diagnostic that can analyze alterations in a panel of genes that are predictive of response across three non-small cell lung cancer treatments in the second quarter of 2017. The rising R&D in Cancer diseases will create significant demand for advanced next generation sequencing and various other products, kits, instrument, and other medical devices.

A Full Report of Life Science Instrumentation Market is Available at https://www.omrglobal.com/industry-reports/life-science-instrumentation-market

Global life science Instrumentation Market Segmentation

By Technology
• Chromatography
• Spectroscopy
• Polymerase Chain Reaction (PCR)
• Clinical Chemistry Analyzers
• Immunoassays
• Next Generation Sequencing (NGS)
• Flow Cytometry
• Microscopy
• Others( Centrifuges, Electrophoresis)

By End-User
• Pharmaceutical & Biotechnology Companies
• Research Institutes
• Hospitals and Laboratories

Global life science Instrumentation Market – Segment by Region

North America
• US
• Canada

Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World
• Latin America
• Middle East and Africa

Company Profiles
• Agilent Technologies, Inc.
• Becton, Dickinson and Co.
• Bio-Rad Laboratories, Inc.
• Biomerieux S.A.
• Bruker Corp.
• Carl Zeiss AG
• Danaher Corp.
• Eppendorf AG
• General Electric Co.
• Hitachi High-Tech Corp.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/life-science-instrumentation-market

For More Information, Visit https://www.omrglobal.com/

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404

About us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.